Why the study?
Does timely and potent adjunctive corticosteroid therapy prevent coronary artery complication in high-risk patients with Kawasaki Disease?
Does timely and potent adjunctive corticosteroid therapy prevent coronary artery complication in high-risk patients with Kawasaki Disease?
Early and potent adjunctive corticosteroid therapy is important for preventing coronary artery complications in high-risk patients with Kawasaki Disease.
Answers are grounded in this paper and cite their sources.
Supports early corticosteroid use in high-risk KD care; reinforces Level 1 meta-analytic evidence for coronary prevention.
This study highlights the importance of timing to prevent coronary artery complication in treating KD. High-risk patients with KD benefit greatly from a timely and potent adjunctive corticosteroid therapy strategy.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: